ARQT — Arcutis Biotherapeutics, Inc. stock price, charts and financials

QT58Arcutis Biotherapeutics, Inc.

Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
25.38
-1.08-4.08%
OverviewShort InterestFilings
ARQTQT58Arcutis Biotherapeutics, Inc.·NASDAQ
25.38-4.08%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Sep 18, 20264Statement of changes in beneficial ownership
Sep 17, 20264Statement of changes in beneficial ownership
Sep 10, 20264Statement of changes in beneficial ownership
Aug 28, 20264Statement of changes in beneficial ownership
Aug 24, 20264Statement of changes in beneficial ownership
Aug 21, 20264Statement of changes in beneficial ownership
Aug 19, 20264Statement of changes in beneficial ownership
Aug 14, 2026SC 13GBeneficial ownership statement (passive)
Aug 13, 20264Statement of changes in beneficial ownership
Aug 07, 2026SC 13GBeneficial ownership statement (passive)
Aug 05, 20264Statement of changes in beneficial ownership
Aug 05, 20268-KCurrent report
Aug 05, 20264Statement of changes in beneficial ownership
Aug 05, 20264Statement of changes in beneficial ownership
Aug 05, 202610-QQuarterly report
Jul 17, 20263Initial statement of beneficial ownership
Jul 17, 20264Statement of changes in beneficial ownership
Jul 17, 20264Statement of changes in beneficial ownership
Jul 16, 20268-KCurrent report
Jun 17, 20264Statement of changes in beneficial ownership
Jun 17, 20264Statement of changes in beneficial ownership
Jun 12, 20264/AStatement of changes in beneficial ownership (amended)
Jun 09, 20264Statement of changes in beneficial ownership
Jun 09, 20264Statement of changes in beneficial ownership
Jun 09, 20264Statement of changes in beneficial ownership
#1 / 25 of 521
Page
▼
/ 21